The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV.
Payer BA, Reiberger T, Breitenecker F, Aichelburg MC, Schuster C, Heil PM, Scherzer TM, Ferenci P, Rieger A, Peck-Radosavljevic M; Vienna HIV & Liver Study Group.
Payer BA, et al. Among authors: reiberger t.
J Infect. 2012 Aug;65(2):142-9. doi: 10.1016/j.jinf.2012.02.014. Epub 2012 Mar 10.
J Infect. 2012.
PMID: 22410384